All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Managing flushing and gastrointestinal events associated with delayed-release dimethyl fumarate: Experiences of an international panel

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F14%3A10272275" target="_blank" >RIV/00216208:11110/14:10272275 - isvavai.cz</a>

  • Alternative codes found

    RIV/00064165:_____/14:10272275

  • Result on the web

    <a href="http://dx.doi.org/10.1016/j.msard.2014.03.003" target="_blank" >http://dx.doi.org/10.1016/j.msard.2014.03.003</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1016/j.msard.2014.03.003" target="_blank" >10.1016/j.msard.2014.03.003</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Managing flushing and gastrointestinal events associated with delayed-release dimethyl fumarate: Experiences of an international panel

  • Original language description

    Strategies for monitoring and managing the known adverse event (AE) profile of therapies for relapsing-remitting multiple sclerosis have become key to the optimization of patient outcomes. Delayed-release dimethyl fumarate (DMF) was associated with an increased risk of flushing and gastrointestinal (GI) AEs in clinical trials. A survey of clinicians with significant research experience using delayed-release DMF was conducted to provide guidance to clinicians using delayed-release DMF in clinical practice on the management of flushing and GI tolerability AEs. Recommendations for prophylaxis included educating the patient about flushing and GI AEs associated with delayed-release DMF and recommending administration with food. A variety of symptomatic treatments were utilized during the delayed-release DMF clinical trials in patients presenting with delayed-release DMF-related flushing or GI AEs that were severe or bothersome enough to warrant pharmacological intervention.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

  • CEP classification

    FH - Neurology, neuro-surgery, nuero-sciences

  • OECD FORD branch

Result continuities

  • Project

  • Continuities

    Z - Vyzkumny zamer (s odkazem do CEZ)<br>I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2014

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Multiple Sclerosis and Related Disorders

  • ISSN

    2211-0348

  • e-ISSN

  • Volume of the periodical

    3

  • Issue of the periodical within the volume

    4

  • Country of publishing house

    US - UNITED STATES

  • Number of pages

    7

  • Pages from-to

    513-519

  • UT code for WoS article

  • EID of the result in the Scopus database